LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
revenue	64.55M -	71.10M 10.14%	78.35M 10.20%	89.15M 13.78%	100.87M 13.14%	105.57M 4.66%	117.23M 11.05%	129.37M 10.35%	154.42M 19.37%	161.65M 4.68%	193.48M 19.69%
cost of revenue	19.43M -	22.67M 16.63%	24.19M 6.71%	26.21M 8.39%	30.17M 15.09%	31.63M 4.84%	37.38M 18.18%	44.75M 19.71%	53.04M 18.53%	56.76M 7.00%	72.53M 27.79%
gross profit	45.12M -	48.43M 7.35%	54.17M 11.84%	62.94M 16.19%	70.70M 12.33%	73.94M 4.59%	79.85M 8.00%	84.62M 5.97%	101.38M 19.81%	104.90M 3.47%	120.96M 15.31%
selling and marketing expenses	22.14M -	22.09M 0.25%	22.78M 3.14%	26.11M 14.60%	25.95M 0.60%	27.32M 5.28%	30.34M 11.06%	23.70M 21.88%	27.66M 16.69%	32.92M 19.04%	41.05M 24.70%
general and administrative expenses	12.58M -	13.89M 10.44%	14.01M 0.87%	14.35M 2.46%	17.01M 18.50%	17.69M 3.99%	19.05M 7.72%	22.50M 18.08%	25.50M 13.33%	28.75M 12.72%	31.83M 10.74%
selling general and administrative expenses	34.72M -	35.98M 3.62%	36.79M 2.26%	40.46M 9.97%	42.96M 6.18%	45.01M 4.77%	49.39M 9.75%	46.20M 6.46%	53.16M 15.05%	61.67M 16.01%	66.91M 8.50%
research and development expenses	5.24M -	4.67M 10.91%	5.48M 17.30%	6.14M 12.08%	6.64M 8.06%	8.20M 23.52%	9.28M 13.16%	10.10M 8.87%	11.80M 16.85%	13.29M 12.65%	16.97M 27.62%
other expenses	-182K -	-4K 97.80%	-89K 2,125%	-94K 5.62%	3K 103.19%	235K 7,733.33%	496K 111.06%	-122K 124.60%	-116K 4.92%	-325K 180.17%	-314K 3.38%
cost and expenses	60.03M -	64.00M 6.61%	67.20M 5.00%	72.81M 8.36%	79.76M 9.54%	84.83M 6.35%	96.05M 13.22%	101.05M 5.20%	118.00M 16.78%	131.72M 11.62%	156.40M 18.74%
operating expenses	40.60M -	41.34M 1.82%	43.01M 4.06%	46.60M 8.34%	49.59M 6.42%	53.20M 7.28%	58.67M 10.27%	56.30M 4.04%	64.96M 15.38%	74.96M 15.40%	83.88M 11.89%
interest expense	12K -	5K 58.33%		14K -	21K 50%	2K 90.48%		1.31M -	2.22M 69.39%	986K 55.57%
ebitda	4.52M -	7.85M 73.75%	10.79M 37.49%	16.34M 51.36%	21.10M 29.18%	13.26M 37.16%	21.18M 59.74%	28.20M 33.11%	36.62M 29.88%	30.60M 16.45%	46.60M 52.29%
operating income	4.52M -	6.34M 40.33%	11.51M 81.59%	16.34M 41.89%	21.10M 29.18%	28.21M 33.67%	15.77M 44.11%	19.80M 25.59%	25.55M 29.04%	21.16M 17.17%	37.08M 75.21%
depreciation and amortization	2.79M -	3.33M 19.37%	3.39M 1.80%	3.59M 5.80%	4.05M 12.92%	4.32M 6.63%	5.42M 25.25%	8.39M 55.00%	11.07M 31.86%	9.43M 14.79%	9.52M 0.87%
total other income expenses net	-182K -	-759K 317.03%	271K 135.70%	-94K 134.69%	3K 103.19%	7.71M 256,866.67%	5.91M 23.31%	7.55M 27.79%	8.73M 15.62%	6.33M 27.58%	2.39M 62.17%
income before tax	4.33M -	6.32M 46.03%	11.42M 80.76%	16.24M 42.17%	21.11M 29.95%	28.44M 34.77%	21.68M 23.78%	27.36M 26.19%	34.29M 25.34%	27.49M 19.82%	39.48M 43.60%
income tax expense	1.13M -	2.40M 113.59%	3.67M 52.43%	5.65M 54.17%	3.93M 30.48%	5.50M 40.01%	3.75M 31.92%	6.14M 63.85%	7.38M 20.27%	6.85M 7.13%	9.37M 36.71%
net income	3.20M -	3.92M 22.27%	7.76M 98.16%	10.59M 36.50%	17.18M 62.20%	22.94M 33.57%	17.93M 21.83%	21.22M 18.32%	26.91M 26.80%	20.64M 23.31%	30.11M 45.89%
weighted average shs out	15.32M -	16.61M 8.47%	17.76M 6.92%	18.48M 4.06%	18.96M 2.58%	19.43M 2.45%	19.81M 1.99%	20.25M 2.19%	21.16M 4.50%	21.98M 3.87%	22.22M 1.10%
weighted average shs out dil	15.76M -	17.01M 7.89%	18.32M 7.69%	19.24M 5.05%	20.03M 4.12%	20.24M 1.04%	20.33M 0.41%	20.48M 0.75%	21.48M 4.86%	22.17M 3.24%	22.42M 1.14%
eps	0.21 -	0.24 14.29%	0.44 83.33%	0.57 29.55%	0.91 59.65%	1.18 29.67%	0.91 22.88%	1.05 15.38%	1.27 20.95%	0.94 25.98%	1.36 44.68%
epsdiluted	0.20 -	0.23 15%	0.42 82.61%	0.55 30.95%	0.86 56.36%	1.13 31.40%	0.88 22.12%	1.04 18.18%	1.25 20.19%	0.93 25.60%	1.34 44.09%

NASDAQ:LMAT

LeMaitre Vascular, Inc.

Last Close

77.68

17/05 20:00

Market Cap

1.26B

Beta: 0.99

Volume Today

74.89K

Avg: 103.90K

PE Ratio

47.66

PFCF: 107.70

Dividend Yield

0.96%

Payout:32.88%